Path to IND for Biologics

Information

Current description: Not only do we offer standalone services along any phase of the drug development journey for protein-based biologics, but we also provide integrated services — including bioprocessing, drug substance development, drug product production, and clinical pack and label. Our Path to IND offering completes all of this in as little as 9-months.* Terms and Conditions: Titer levels provided are estimates based on third party results and may vary depending on molecule type or other factors. Timeline from DNA to drug product and start of clinical trials for all path to IND for biologics options may vary depending on molecule type or other factors and are estimates to be finalized after third party cell line development dates are available and confirmed. 9-month timeline will incur additional risk.

Log in

See all the content and easy-to-use features by logging in or registering!